A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis

BACKGROUND: The aim of this study was to evaluate the safety and analgesic efficacy of polmacoxib 2 mg versus placebo in a superiority comparison or versus celecoxib 200 mg in a noninferiority comparison in patients with osteoarthritis (OA). METHODS: This study was a 6-week, phase III, randomized, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Myungchul, Yoo, Juhyung, Kim, Jin Goo, Kyung, Hee-Soo, Bin, Seong-Il, Kang, Seung-Baik, Choi, Choong Hyeok, Moon, Young-Wan, Kim, Young-Mo, Han, Seong Beom, In, Yong, Choi, Chong Hyuk, Kim, Jongoh, Lee, Beom Koo, Cho, Sangsook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Orthopaedic Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705303/
https://www.ncbi.nlm.nih.gov/pubmed/29201297
http://dx.doi.org/10.4055/cios.2017.9.4.439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705303/
https://www.ncbi.nlm.nih.gov/pubmed/29201297
http://dx.doi.org/10.4055/cios.2017.9.4.439

Ejemplares similares